References
- Boyd I W, Rohan A P. Urinary disorders associated with cisapride. Med J Aust 1994; 160: 579–580
- Candura S M, Messori E, Franceschetti G P, et al. Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists. Br J Pharmacol 1996; 118, in press
- Gfi de Groot, de Pagter G F. Effects of cisapride on constipation due to a neurological lesion. Paraplegia 1988; 26: 159–161
- Etienne M, Verlinden M, Brassinne A. Treatment with cisapride of the gastrointestinal and urological sequelae of spinal cord transection: case report. Paraplegia 1988; 26: 162–164
- Franceschetti G P, Candura S M, Messori E, Vicini D, Balestra B, Tonini M. Serotonin potentiates cholinergic neuromuscular transmission in the human isolated detrusor muscle through 5-HT4 receptors: potential therapeutic implications. Urodinamica 1995; 5: 191–193
- Hanson P, Soler J M. Effet du cisapride sur les vessies neurologiques. Acta Belg Med Phys 1989; 12: 81–88
- Mundy A R, Stephenson T P, Wein A J. Urodynamics. Principles, Practice and Application, 2nd ed. Churchill Livingstone, Edinburgh 1994
- Tack J, Coremans G, Janssens J. A risk-benefit assess-xment of cisapride in the treatment of gastrointestinal disorders. Drug Safety 1995; 12: 384–392
- Tonini M, De Ponti F. Serotonin modulation of gastrointestinal motility. Serotonin and Gastrointestinal Function, T S Gaginella, J J Galligan. CRC Press, Boca Raton, FL 1995; 53–84
- Tonini M, Messori E, Franceschetti G P, et al. Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. Br J Pharmacol 1994; 113: 1–2